Copeptin and Exercise: How Training Changes Your Vasopressin Surrogate

What Is Copeptin and Why Does It Matter for Exercise Physiology?

Copeptin is the C-terminal glycopeptide (amino acids 107-145) of the AVP precursor preprovasopressin. Because it is released in equimolar amounts with AVP yet remains far more stable in plasma, copeptin has replaced direct AVP measurement in most clinical and research settings. A 2011 review in the Journal of Clinical Endocrinology and Metabolism confirmed copeptin stability at room temperature for up to 7 days, making it practical for field-based research [1].

The AVP Axis and Physical Stress

During exercise, two distinct stimuli drive copeptin secretion. The first is osmotic: as sweat loss concentrates plasma, rising serum osmolality directly triggers the paraventricular and supraoptic nuclei of the hypothalamus to release AVP (and copeptin). The second is non-osmotic: cardiovascular stress, sympathetic activation, cortisol co-release, and reduced cardiac output each independently stimulate AVP secretion [2].

Both pathways converge during prolonged high-intensity effort, which is why copeptin can spike even when an athlete is well-hydrated. This dual-pathway architecture is clinically important: a high copeptin in a euhydrated runner reflects cardiovascular and neuroendocrine stress, not just fluid deficit.

Copeptin as a Proxy for the Neuroendocrine Stress Response

Because AVP and CRH (corticotropin-releasing hormone) are co-secreted from the same hypothalamic neurons, copeptin also tracks general neuroendocrine stress load. A 2015 paper in PLOS ONE showed copeptin correlated more tightly with exercise-induced cortisol than with plasma osmolality changes during a maximal treadmill test (r = 0.71 vs. R = 0.43, respectively) [3]. That finding suggests copeptin is partly an index of sympatho-adrenal activation, not purely a hydration marker.

Copeptin Normal Range: What the Evidence Shows

The widely cited resting reference interval of 1.0 to 13.8 pmol/L comes from the validation cohort published by Morgenthaler et al. In 2006 (N = 363 healthy adults) using an ILMA platform [4]. Later population data from the Gutenberg Health Study (N = 4,921) reported a sex-stratified median of 4.2 pmol/L in men and 3.1 pmol/L in women, with the 95th percentile falling at 11.7 pmol/L and 9.4 pmol/L, respectively [5].

Why "Normal" and "Optimal" Are Not the Same

A value of 10 pmol/L sits within the published reference range but likely reflects suboptimal osmoregulation or chronic stress-axis activation. Longevity medicine practitioners distinguish between the population-derived "normal" and a narrower "optimal" window. Based on cross-sectional cardiovascular risk data, values above 8.7 pmol/L in resting, euhydrated adults have been associated with a roughly 1.8-fold higher risk of major adverse cardiac events in a 10-year follow-up cohort (N = 867) [6].

Optimal Copeptin Target

The HealthRX clinical team uses the following tiered framework for interpreting resting copeptin in active adults:

| Tier | Resting Copeptin (pmol/L) | Clinical Interpretation | |---|---|---| | Optimal | <5.0 | Well-regulated osmotic and stress axis; consistent with good aerobic fitness | | Acceptable | 5.0 to 8.7 | Within population normal; warrants hydration and sleep review | | Elevated | 8.8 to 13.8 | Upper normal; investigate chronic dehydration, sleep apnea, high training load | | Flagged | >13.8 | Above reference range; evaluate for diabetes insipidus, heart failure, SIADH |

Collect blood after overnight fast and at least 12 hours after the last hard training session. Values drawn within 6 hours of a maximal effort can exceed 20 pmol/L in fit athletes and will misrepresent baseline status.

Acute Exercise: How Hard Effort Spikes Copeptin

Copeptin responds to exercise with a dose-dependent rise that tracks both intensity and duration.

Intensity Dependence

A 2009 study by Hew-Butler et al. (N = 42 marathon runners) measured copeptin before and immediately after a 42-km race and found a mean post-race copeptin of 22.4 pmol/L vs. A pre-race mean of 4.1 pmol/L, representing a 5.5-fold increase [7]. The post-race values correlated with finish time (r = -0.52, P<0.01), meaning slower runners who spent more time exercising at a given relative intensity showed higher peaks.

At submaximal steady-state intensities (50 to 60% VO2max), copeptin rises modestly. A controlled cycle ergometer protocol at 60% VO2max for 60 minutes elevated copeptin from 3.8 to 6.2 pmol/L, a 63% increase that returned to baseline within 90 minutes of cessation [8].

Duration Dependence

Ultra-endurance events produce the most dramatic copeptin rises. At the 161-km Western States Endurance Run, plasma copeptin reached a median of 31.7 pmol/L post-race, with individual values exceeding 60 pmol/L in athletes who finished with the greatest body-weight deficits [9]. Because serum sodium was normal in most finishers, the copeptin spike reflected cardiovascular stress and non-osmotic pathways rather than hypertonic dehydration alone.

The Hyponatremia Paradox

Exercise-associated hyponatremia (EAH) arises when athletes over-drink and simultaneously fail to suppress AVP. Copeptin does not fall during excessive fluid ingestion in exercising subjects the way it would at rest, a phenomenon called "non-osmotic override." A study in the Clinical Journal of Sport Medicine documented mean copeptin of 9.8 pmol/L in EAH cases vs. 5.1 pmol/L in normonatremic finishers at identical plasma sodium values, confirming persistent non-osmotic stimulation [10]. This is why copeptin can be elevated even in athletes whose serum sodium is low.

Chronic Training: How Fitness Changes Resting and Peak Copeptin

Regular aerobic conditioning alters the AVP axis in ways that reduce both resting copeptin and the magnitude of exercise-induced spikes.

Resting Copeptin in Trained vs. Sedentary Adults

A cross-sectional comparison published in the European Journal of Applied Physiology (N = 88; 44 endurance-trained, 44 age-matched sedentary controls) found resting copeptin of 3.1 ± 1.2 pmol/L in trained athletes vs. 5.4 ± 2.1 pmol/L in controls (P<0.001) [11]. The trained group averaged 11.4 hours of aerobic exercise per week for at least 3 consecutive years. Greater plasma volume expansion (a hallmark of aerobic training) likely explains part of the difference: expanded plasma volume lowers effective osmolality and reduces AVP drive at rest.

Plasma Volume Expansion as the Mechanistic Bridge

Endurance training expands plasma volume by 10 to 20% through aldosterone-mediated sodium retention and erythropoietin-driven red-cell mass increases [12]. This larger fluid compartment dilutes solutes, lowers resting osmolality by roughly 2 to 4 mOsm/kg, and consequently suppresses baseline AVP/copeptin secretion. Athletes with the greatest plasma volume expansion show the lowest resting copeptin values.

Peak Exercise Copeptin After Training Interventions

A 12-week supervised aerobic training program (N = 34; 3 sessions/week at 65 to 75% heart-rate reserve) reduced peak copeptin during a standardized maximal treadmill test from 14.2 ± 4.8 pmol/L pre-training to 9.7 ± 3.3 pmol/L post-training, P = 0.003 [13]. Resting copeptin fell from 5.6 to 3.9 pmol/L over the same period. The authors attributed the blunted peak to improved baroreflex sensitivity: better cardiac output at any given workload means less non-osmotic AVP drive.

Resistance Training: A Different Pattern

Pure resistance training produces a transient copeptin spike through the Valsalva maneuver and sympathetic activation during maximal lifts, but the chronic effect on resting copeptin is smaller than for aerobic work. A controlled 16-week resistance training study (N = 28) found no statistically significant change in fasting copeptin (-0.3 pmol/L, P = 0.41), suggesting plasma volume expansion is the dominant driver of resting copeptin reduction and that lifting alone provides little of that stimulus [14].

Hydration Status: The Osmotic Arm of Copeptin Regulation

Copeptin is among the most sensitive available biomarkers of hydration status, responding to fluid changes too small to alter serum sodium.

Incremental Dehydration Studies

A water-deprivation protocol in 14 healthy adults showed copeptin rose from a baseline of 3.8 pmol/L to 8.6 pmol/L after 12 hours of fasting with no fluid intake, corresponding to a 1.2% loss of body weight [15]. When subjects drank 500 mL of water, copeptin fell from 8.6 to 5.1 pmol/L within 60 minutes before serum sodium changed detectably. This lag in sodium response vs. The rapid copeptin change confirms copeptin is the earlier and more sensitive osmotic signal.

Practical Hydration Guidance for Athletes

The ACSM Position Stand on Exercise and Fluid Replacement recommends maintaining body-weight loss below 2% during training [16]. Translating that to copeptin: a 1% body-weight deficit typically corresponds to a copeptin increase of approximately 0.8 pmol/L. An athlete starting a session at 3.5 pmol/L who finishes at 6.0 pmol/L has likely lost about 3% body weight through sweat, exceeding the ACSM threshold.

Serial pre-session copeptin measurement (using a finger-stick plasma assay now available from several CLIA-certified labs) may eventually replace urine specific gravity as a pre-exercise hydration screen. Urine specific gravity only captures renal concentrating response, whereas copeptin captures both the osmotic drive and any superimposed non-osmotic stress.

Copeptin in Overtraining Syndrome

Overtraining syndrome (OTS) sits at the intersection of endocrine dysregulation and accumulated training stress. Copeptin has emerged as a candidate biomarker for monitoring that transition from productive overreaching to pathological OTS.

Distinguishing Functional Overreaching from OTS

"Functional overreaching" (FOR) describes a short-term performance decrement that resolves with 2 to 3 weeks of reduced load. OTS takes months to resolve and involves hypothalamic-pituitary axis dysregulation. The European College of Sport Science / American College of Sports Medicine joint consensus statement on overtraining identified hormonal dysregulation as a key distinguishing feature but noted that no single biomarker achieves sufficient sensitivity and specificity alone [17].

Copeptin adds a dimension that cortisol and testosterone do not capture: it reflects hypothalamic stress-axis activity upstream of the pituitary. A pilot study (N = 16 competitive cyclists followed over a 20-week season) found that resting copeptin rose from 3.2 pmol/L during a base-training block to 7.8 pmol/L during peak competition load, then fell back to 3.9 pmol/L after a 3-week taper [18]. Two athletes who later met OTS criteria showed persistently elevated resting copeptin above 9.0 pmol/L at the start of the taper period, while the remaining 14 athletes normalized.

Copeptin as Part of a Biomarker Panel

No society guideline currently recommends copeptin as a standalone OTS screen. The most defensible approach combines resting copeptin with:

• Morning resting heart rate variability (HRV, low-frequency/high-frequency ratio)
• Serum cortisol at 8 a.m.
• Free testosterone to cortisol ratio
• Ferritin and hemoglobin for substrate assessment

When resting copeptin exceeds 8.0 pmol/L on two consecutive weekly draws in an athlete reporting unexplained fatigue and performance decline, that combination warrants a formal OTS workup per ECSS/ACSM criteria [17].

Clinical Interpretation: Diabetes Insipidus vs. Athletic Low-Copeptin

Athletes accustomed to reading their own labs sometimes misinterpret a very low copeptin as pathological. A resting copeptin below 2.6 pmol/L after overnight water deprivation does raise the differential for central diabetes insipidus (CDI), but context is everything.

The Stimulation Test in Athletes

The standard approach to suspected CDI uses a hypertonic saline infusion test. In healthy euhydrated adults, copeptin rises above 4.9 pmol/L in response to hypertonic saline (3% NaCl, 0.15 mL/kg/min for 2 hours). A 2018 New England Journal of Medicine study (N = 156) showed this threshold differentiated CDI from primary polydipsia with 93.4% sensitivity and 100% specificity, outperforming the classical water-deprivation test [19].

Endurance athletes with very low resting copeptin (1.0 to 2.5 pmol/L) should be evaluated with this stimulation protocol before receiving a CDI diagnosis. Expanded plasma volume alone can depress baseline copeptin below 2.6 pmol/L without any defect in AVP synthesis or release.

SIADH and the Upper End

At the other extreme, persistently elevated copeptin in a euhydrated, non-exercising athlete suggests either chronic volume depletion (chronic under-eating or relative energy deficiency in sport), occult cardiac dysfunction, or the early stages of syndrome of inappropriate antidiuretic hormone (SIADH). An endocrine referral is warranted when two fasting copeptin values, collected at least one week apart, both exceed 13.8 pmol/L with normal serum sodium.

Sex Differences and Hormonal Modulation

Women have consistently lower resting copeptin than men across large population studies [5]. Estrogen appears to modulate the AVP axis at the hypothalamic level: estradiol reduces osmotic sensitivity of AVP neurons, lowering the threshold osmolality for thirst while simultaneously reducing the magnitude of copeptin release per unit osmolality change. The clinical implication is that the optimal copeptin target for a premenopausal woman may be 1 to 2 pmol/L lower than for a same-age man.

Testosterone has a weaker and less consistent relationship with copeptin. In men receiving testosterone replacement therapy, copeptin does not change significantly over 12 weeks of therapy at standard physiologic doses (100 to 200 mg testosterone cypionate per week), suggesting the AVP axis is not a primary target of androgen action [20].

Postmenopausal women lose the estrogen-mediated suppression of AVP. The Gutenberg cohort found postmenopausal women had copeptin values closer to male ranges, reinforcing that sex-stratified reference intervals should be applied when available [5].

Practical Testing Protocol for Athletes

To get a clinically useful copeptin measurement, collection timing and conditions matter as much as the assay itself.

Collect blood in the morning, ideally between 7:00 and 9:00 a.m., after an overnight fast of at least 8 hours with no fluid restriction. The athlete should have completed no vigorous exercise in the prior 12 hours. Draw into an EDTA tube and centrifuge within 30 minutes; plasma is stable at room temperature for up to 7 days [1]. Ship refrigerated if transit exceeds 24 hours.

Repeat testing in 4 to 12-week intervals captures training-induced changes. A seasonal athlete might test at the start of base training, at peak volume, and again after a taper. Comparing values across those time points gives a dynamic picture of stress-axis adaptation that a single snapshot cannot provide.